EGFR and lung carcinoma: This AI approach has been used in patients with somatic mutations in lung cancer to better classify the type of tumors using four large datasets and with focus on kRAS and epidermal growth factor receptor (EGFR), enabling a 75% prediction of mutations associated with these genes [16].